Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,511 articles

Articles by Daniel Marsh

Indian Equities Retreat on Geopolitical Tensions and Oil Price Surge
Markets

Indian Equities Retreat on Geopolitical Tensions and Oil Price Surge

Indian benchmark indices fell sharply on Thursday, with the Sensex dropping 1.20%, as escalating oil prices and doubts over a U.S.-Iran ceasefire prompted a broad sell-off. Banking stocks were the hardest hit.

HDB IBN INFY WIT USO XLF
Cramer Sees Relief Rally Highlighting Institutional Favorites
Markets

Cramer Sees Relief Rally Highlighting Institutional Favorites

Jim Cramer highlighted stocks like Sherwin-Williams, Caterpillar, Home Depot, and Goldman Sachs as potential institutional favorites following Wednesday's market surge. Futures slipped Thursday as oil rose on ceasefire doubts.

SHW CAT HD GS MU WDC STX SSNLF XLK USO
Indian Equities Retreat as Oil Surge Rekindles Macroeconomic Concerns
Markets

Indian Equities Retreat as Oil Surge Rekindles Macroeconomic Concerns

Indian stock benchmarks fell sharply on Thursday, with the Sensex dropping 1.51% and the Nifty 50 down 1.12%, as a rebound in oil prices revived fears over inflation and growth.

HDB IBN INFY MCHI WIT
ASX 200 Edges Higher on Bank Strength, Tech Sell-Off Weighs
Markets

ASX 200 Edges Higher on Bank Strength, Tech Sell-Off Weighs

Australian shares closed slightly higher on Thursday, with gains in major banks offsetting a sharp decline in the technology sector. The benchmark index reached its highest level in five weeks.

BHP RIO BEN XLE XLF XLK
FTSE 100 Steady Near 10,600 as Oil Rebound Threatens Ceasefire Gains
Markets

FTSE 100 Steady Near 10,600 as Oil Rebound Threatens Ceasefire Gains

The FTSE 100 held steady near 10,600 on Thursday, consolidating after a sharp rally, as renewed doubts over a U.S.-Iran ceasefire sent oil prices climbing. The Bank of England anticipates a rise in mortgage demand for Q2.

BP SHEL USO XLE XLF
Markets React to Geopolitical Tensions and Corporate Governance Moves
Markets

Markets React to Geopolitical Tensions and Corporate Governance Moves

Global equities faced pressure Thursday as renewed geopolitical worries in West Asia rattled Indian and Asian benchmarks. Meanwhile, corporate news centered on governance shifts at Obayashi and valuation reviews for Rio Tinto and AtriCure.

RIO ATRC CFR GLD
Analyst Sees 50% Upside for Amazon Despite Massive AI Investment
Analysis

Analyst Sees 50% Upside for Amazon Despite Massive AI Investment

BNP Paribas reaffirms a $320 price target for Amazon, suggesting 50% upside, as the company proceeds with a $200 billion AI infrastructure investment for 2026.

AMZN GOOGL MSFT GS
Indian Markets Rocket on Geopolitical Calm and RBI Hold
Markets

Indian Markets Rocket on Geopolitical Calm and RBI Hold

Indian equity benchmarks posted their strongest gains in years on Wednesday, propelled by easing Middle East tensions and the Reserve Bank of India's decision to maintain interest rates. The Sensex jumped 2,946 points.

XLF XLE USO FXI
Soleno Halts European Drug Review Following $2.9B Neurocrine Acquisition
Markets

Soleno Halts European Drug Review Following $2.9B Neurocrine Acquisition

Soleno Therapeutics has withdrawn its European marketing application for VIOKAT, a day after agreeing to a $2.9 billion all-cash acquisition by Neurocrine Biosciences. The move halts a regulatory review previously expected to conclude by mid-2026.

NBIX
Indian Equities Climb on IT Rally Ahead of RBI Policy, Earnings
Markets

Indian Equities Climb on IT Rally Ahead of RBI Policy, Earnings

Indian benchmarks advanced Tuesday, with the Nifty 50 closing above 23,100, driven by a rally in IT stocks ahead of quarterly earnings and the RBI's policy decision.

INFY FXI
Hologic $18.3B Take-Private Finalized, CEO Exits as Stock Leaves S&P 500
Markets

Hologic $18.3B Take-Private Finalized, CEO Exits as Stock Leaves S&P 500

Hologic has received all required approvals for its $18.3 billion acquisition by Blackstone and TPG, with the deal closing around April 7. CEO Steve MacMillan will retire upon completion.

HOLX BX SIEGY GEHC BDX CASY
Enovix Surges 12% Amid Analyst Shifts; Indian Markets Slump on Oil Spike
Markets

Enovix Surges 12% Amid Analyst Shifts; Indian Markets Slump on Oil Spike

Enovix shares rallied nearly 12% on Monday despite below-average volume and divergent analyst views. Meanwhile, Indian equity indices tumbled over 800 points as Brent crude surged past $111, stoking inflation fears.

ENVX SBH VGZ FXI MCHI USO